fda bpc-157 ineligible for compounding 503a 503b FDA's own advisory committee voted 8-6 Thursday. BPC-157, on the list now, ulcerative colitis. staff argued against it, laid out the data gaps, the whole case. Panel overruled them The peptide regulatory landscape in

Neuroprotection Against Parkinsons Models MPTP selectively destroys nigrostriatal dopaminergic neurons, producing tremor, rigidity, akinesia, and catalepsy in rodents

Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial

For an academic group or a private lab this means a typical 2-5 working-day delivery without the paperwork associated with a non-EU import

CDC injection-safety guidance On February 27, 2026, HHS Secretary Kennedy announced that GHK-Cu is among approximately 14 peptides expected to return to Category 1

Chronic heavy alcohol consumption impairs B12 status through poor dietary intake, malabsorption, and liver disease